Results 151 to 160 of about 422,131 (199)
Some of the next articles are maybe not open access.
Gram-positive bacterial infection in severe sepsis
Clinical Intensive Care, 2002They may be involved in the initial insult precipitating an intensive care admission, but are also often acquired as nosocomial pathogens by critically ill patients. Although sepsis in the context of critical illness is a highly complex process often involving polymicrobial infection, 5-8 discussion of Gr am-po sitive sep sis in isolation is not ...
P Hopkins, S Sriskandan
openaire +1 more source
Serological detection of Gram-positive bacterial infection around prostheses
The Journal of Bone and Joint Surgery. British volume, 2000Coagulase-negative staphylococci produce an exocellular glycolipid antigen which has potential as a serological marker of infection in bone. The value of this newly detected antigen was investigated by enzyme-linked immunosorbent assay (ELISA) in 15 patients with culture-proven infection of prostheses caused by Gram-positive bacteria.
M, Rafiq +6 more
openaire +2 more sources
Dalton Transactions, 2023
Coumarin-modified ruthenium complexes could efficiently disrupt bacterial membrane and cause the death of bacteria.
Hai-Yan Huang +8 more
openaire +2 more sources
Coumarin-modified ruthenium complexes could efficiently disrupt bacterial membrane and cause the death of bacteria.
Hai-Yan Huang +8 more
openaire +2 more sources
Teicoplanin- A New Agent for Gram-Positive Bacterial Infections
Infection Control & Hospital Epidemiology, 1988Gram-positive bacterial infections remain a serious challenge for infectious disease practitioners. Many gram-positive organisms are developing new methods of antibiotic resistance, thus rendering our standard antimicrobial agents ineffective.
M, Eggleston, J, Ofosu
openaire +2 more sources
Management of gram-positive bacterial infections in patients with cancer
Leukemia & Lymphoma, 2011Bacterial infections, particularly those due to gram-positive bacteria, continue to predominate in patients with cancer. Coagulase-negative and coagulase-positive staphylococci and enterococci remain as common pathogenic microorganisms. Clostridium difficile has emerged as a significant pathogen.
Kosmidis, Christos I +1 more
openaire +3 more sources
Daptomycin Therapy for Invasive Gram-Positive Bacterial Infections in Children
Pediatric Infectious Disease Journal, 2007Clinical improvement is often delayed among children with invasive infections caused by multidrug resistant Gram-positive bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) despite use of standard antimicrobial therapy.
Monica I, Ardura +5 more
openaire +2 more sources
Therapy of Gram-Positive Bacterial Infections
Veterinary Clinics of North America: Small Animal Practice, 1988This article considers the important features of gram-positive bacteria that relate to chemotherapy and the clinical pharmacology of the drugs of choice for treating these infections.
openaire +2 more sources
Glycopeptides and Antibiotics for Gram-positive Bacterial Infections
2016Glycopeptides, lipopeptides and other antibiotics, such as linezolid and quinupristin/dalfopristin , are exclusively used for the treatment of infections caused by Gram-positive bacteria. Limited information is available about the dosing of these antibiotics in obese patients.
Syed Tabish R. Zaidi, Brett Janson
openaire +1 more source
Benefit-Risk Assessment of Linezolid for Serious Gram-Positive Bacterial Infections
Drug Safety, 2008Linezolid is an oxazolidinone, a new class of antibacterial with a unique mechanism of action, namely inhibition of the formation of a functional 70S initiation complex in the 50S bacterial ribosomal subunit. Linezolid is highly active against multidrug-resistant Gram-positive cocci, including meticillin-resistant Staphylococcus aureus (MRSA ...
Matthew E, Falagas +1 more
openaire +2 more sources
Antibiotic candidates for Gram-positive bacterial infections induce multidrug resistance
Science Translational MedicineSeveral antibiotic candidates are in development against Gram-positive bacterial pathogens, but their long-term utility is unclear. To investigate this issue, we studied the laboratory evolution of resistance to antibiotics that have not yet reached the market.
Martins, Ana +19 more
openaire +3 more sources

